請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44771完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 郭明良 | |
| dc.contributor.author | Yi-Ju Chen | en |
| dc.contributor.author | 陳怡儒 | zh_TW |
| dc.date.accessioned | 2021-06-15T03:54:34Z | - |
| dc.date.available | 2015-09-09 | |
| dc.date.copyright | 2010-09-09 | |
| dc.date.issued | 2010 | |
| dc.date.submitted | 2010-06-29 | |
| dc.identifier.citation | Adachi, N. (2003). '[A survey of social insurance payment for intracranial surgery segments--annual report of Statistics and Information Department, Ministry of Health, Labor and Welfare, Japan, 2000. No. 13, in series of articles: controversy and reform proposals concerning insured medical care in neurosurgery].' No Shinkei Geka 31(3): 333-336.
Adams, R. H. and K. Alitalo (2007). 'Molecular regulation of angiogenesis and lymphangiogenesis.' Nat Rev Mol Cell Biol 8(6): 464-478. Arnesen, T., M. J. Betts, et al. (2006). 'Characterization of hARD2, a processed hARD1 gene duplicate, encoding a human protein N-alpha-acetyltransferase.' BMC Biochem 7: 13. Arnesen, T., X. Kong, et al. (2005). 'Interaction between HIF-1 alpha (ODD) and hARD1 does not induce acetylation and destabilization of HIF-1 alpha.' FEBS Lett 579(28): 6428-6432. Asaumi, M., K. Iijima, et al. (2005). 'Interaction of N-terminal acetyltransferase with the cytoplasmic domain of beta-amyloid precursor protein and its effect on A beta secretion.' J Biochem (Tokyo) 137(2): 147-155. Aurello, P., R. Bellagamba, et al. (2009). 'Apoptosis and microvessel density in gastric cancer: correlation with tumor stage and prognosis.' Am Surg 75(12): 1183-1188. Brown, L. F., B. Berse, et al. (1993). 'Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.' Cancer Res 53(19): 4727-4735. Carmeliet, P. (2005). 'Angiogenesis in life, disease and medicine.' Nature 438(7070): 932-936. Carmeliet, P. and R. K. Jain (2000). 'Angiogenesis in cancer and other diseases.' Nature 407(6801): 249-257. Carmeliet, P. and M. Tessier-Lavigne (2005). 'Common mechanisms of nerve and blood vessel wiring.' Nature 436(7048): 193-200. Chan, A. O., J. M. Luk, et al. (1999). 'Molecular biology of gastric carcinoma: from laboratory to bedside.' J Gastroenterol Hepatol 14(12): 1150-1160. Chung, C. K. and H. N. Antoniades (1992). 'Expression of c-sis/platelet-derived growth factor B, insulin-like growth factor I, and transforming growth factor alpha messenger RNAs and their respective receptor messenger RNAs in primary human gastric carcinomas: in vivo studies with in situ hybridization and immunocytochemistry.' Cancer Res 52(12): 3453-3459. Cohen, H. Y., S. Lavu, et al. (2004). 'Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis.' Mol Cell 13(5): 627-638. Contag, P. R., I. N. Olomu, et al. (1998). 'Bioluminescent indicators in living mammals.' Nat Med 4(2): 245-247. Correia, M., J. C. Machado, et al. (2009). 'Basic aspects of gastric cancer.' Helicobacter 14 Suppl 1: 36-40. Crabtree, J. E., J. I. Wyatt, et al. (1994). 'Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa.' J Clin Pathol 47(1): 61-66. Crum, R., S. Szabo, et al. (1985). 'A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment.' Science 230(4732): 1375-1378. Currie, M. J., S. P. Gunningham, et al. (2002). 'Expression of the angiopoietins and their receptor Tie2 in human renal clear cell carcinomas; regulation by the von Hippel-Lindau gene and hypoxia.' J Pathol 198(4): 502-510. Di Gennaro, E., F. Bruzzese, et al. (2004). 'Acetylation of proteins as novel target for antitumor therapy: review article.' Amino Acids 26(4): 435-441. Ebert, M. P., J. Yu, et al. (2000). 'Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer.' Br J Cancer 82(11): 1795-1800. El-Omar, E. M., M. Carrington, et al. (2000). 'Interleukin-1 polymorphisms associated with increased risk of gastric cancer.' Nature 404(6776): 398-402. Enholm, B., K. Paavonen, et al. (1997). 'Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia.' Oncogene 14(20): 2475-2483. Folkman, J. (1995). 'Angiogenesis in cancer, vascular, rheumatoid and other disease.' Nat Med 1(1): 27-31. Folkman, J. and R. Cotran (1976). 'Relation of vascular proliferation to tumor growth.' Int Rev Exp Pathol 16: 207-248. Forsythe, J. A., B. H. Jiang, et al. (1996). 'Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.' Mol Cell Biol 16(9): 4604-4613. Fu, M., C. Wang, et al. (2002). 'Acetylation in hormone signaling and the cell cycle.' Cytokine Growth Factor Rev 13(3): 259-276. Gerber, H. P., F. Condorelli, et al. (1997). 'Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.' J Biol Chem 272(38): 23659-23667. Gimbrone, M. A., Jr., R. S. Cotran, et al. (1974). 'Human vascular endothelial cells in culture. Growth and DNA synthesis.' J Cell Biol 60(3): 673-684. Gleadle, J. M., B. L. Ebert, et al. (1995). 'Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents.' Am J Physiol 268(6 Pt 1): C1362-1368. Goldberg, M. A. and T. J. Schneider (1994). 'Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin.' J Biol Chem 269(6): 4355-4359. Guo, Y. S., R. D. Beauchamp, et al. (1993). 'Insulinlike growth factor-binding protein modulates the growth response to insulinlike growth factor 1 by human gastric cancer cells.' Gastroenterology 104(6): 1595-1604. Harris, A. L. (2002). 'Hypoxia--a key regulatory factor in tumour growth.' Nat Rev Cancer 2(1): 38-47. Hockel, M. and P. Vaupel (2001). 'Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects.' J Natl Cancer Inst 93(4): 266-276. Hofler, H. and K. F. Becker (2003). 'Molecular mechanisms of carcinogenesis in gastric cancer.' Recent Results Cancer Res 162: 65-72. Hohenberger, P. and S. Gretschel (2003). 'Gastric cancer.' Lancet 362(9380): 305-315. Ichikura, T., S. Tomimatsu, et al. (2001). 'Prognostic significance of the expression of vascular endothelial growth factor (VEGF) and VEGF-C in gastric carcinoma.' J Surg Oncol 78(2): 132-137. Iida, S., O. Katoh, et al. (1994). 'Expression of fibroblast growth factor gene family and its receptor gene family in the human upper gastrointestinal tract.' Biochem Biophys Res Commun 199(3): 1113-1119. Jeong, J. W., M. K. Bae, et al. (2002). 'Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation.' Cell 111(5): 709-720. Jiang, Y., L. Wang, et al. (2004). 'A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer.' Clin Exp Metastasis 21(8): 755-764. Johnson, S. M. and B. M. Evers (2008). 'Translational research in gastric malignancy.' Surg Oncol Clin N Am 17(2): 323-340, viii. Kasinathan, C., P. Ramaprasad, et al. (2005). 'Identification and characterization of tyrosylprotein sulfotransferase from human saliva.' Int J Biol Sci 1(4): 141-145. Kitadai, Y., K. Haruma, et al. (1998). 'Expression of interleukin-8 correlates with vascularity in human gastric carcinomas.' Am J Pathol 152(1): 93-100. Kondo, Y., S. Arii, et al. (2000). 'Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.' Clin Cancer Res 6(2): 622-630. Langer, R., H. Conn, et al. (1980). 'Control of tumor growth in animals by infusion of an angiogenesis inhibitor.' Proc Natl Acad Sci U S A 77(7): 4331-4335. Lim, J. H., Y. S. Chun, et al. (2008). 'Hypoxia-inducible factor-1alpha obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of beta-catenin.' Cancer Res 68(13): 5177-5184. Lim, J. H., J. W. Park, et al. (2006). 'Human arrest defective 1 acetylates and activates beta-catenin, promoting lung cancer cell proliferation.' Cancer Res 66(22): 10677-10682. Liu, Y., S. R. Cox, et al. (1995). 'Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer.' Circ Res 77(3): 638-643. Mahlknecht, U. and D. Hoelzer (2000). 'Histone acetylation modifiers in the pathogenesis of malignant disease.' Mol Med 6(8): 623-644. Melillo, G., T. Musso, et al. (1995). 'A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter.' J Exp Med 182(6): 1683-1693. Murray-Rust, T. A., N. J. Oldham, et al. (2006). 'Purified recombinant hARD1 does not catalyse acetylation of Lys532 of HIF-1alpha fragments in vitro.' FEBS Lett 580(8): 1911-1918. Naef, M., M. Yokoyama, et al. (1996). 'Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma.' Int J Cancer 66(3): 315-321. Nguyen, M., Y. Shing, et al. (1994). 'Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane.' Microvasc Res 47(1): 31-40. Oh, H., H. Takagi, et al. (1999). 'Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells.' J Biol Chem 274(22): 15732-15739. Parkin, D. M., F. Bray, et al. (2005). 'Global cancer statistics, 2002.' CA Cancer J Clin 55(2): 74-108. Reynolds, T. Y., S. Rockwell, et al. (1996). 'Genetic instability induced by the tumor microenvironment.' Cancer Res 56(24): 5754-5757. Skobe, M. and N. E. Fusenig (1998). 'Tumorigenic conversion of immortal human keratinocytes through stromal cell activation.' Proc Natl Acad Sci U S A 95(3): 1050-1055. Sugiura, N., S. M. Adams, et al. (2003). 'An evolutionarily conserved N-terminal acetyltransferase complex associated with neuronal development.' J Biol Chem 278(41): 40113-40120. Timar, J., B. Dome, et al. (2001). 'Angiogenesis-dependent diseases and angiogenesis therapy.' Pathol Oncol Res 7(2): 85-94. Tomimatsu, S., T. Ichikura, et al. (2001). 'Significant correlation between expression of interleukin-1alpha and liver metastasis in gastric carcinoma.' Cancer 91(7): 1272-1276. Tribioli, C., M. Mancini, et al. (1994). 'Isolation of new genes in distal Xq28: transcriptional map and identification of a human homologue of the ARD1 N-acetyl transferase of Saccharomyces cerevisiae.' Hum Mol Genet 3(7): 1061-1067. Tuder, R. M., B. E. Flook, et al. (1995). 'Increased gene expression for VEGF and the VEGF receptors KDR/Flk and Flt in lungs exposed to acute or to chronic hypoxia. Modulation of gene expression by nitric oxide.' J Clin Invest 95(4): 1798-1807. Ueki, T., T. Koji, et al. (1995). 'Expression of basic fibroblast growth factor and fibroblast growth factor receptor in advanced gastric carcinoma.' J Pathol 177(4): 353-361. Vaupel, P., D. K. Kelleher, et al. (2001). 'Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy.' Semin Oncol 28(2 Suppl 8): 29-35. Waltenberger, J., U. Mayr, et al. (1996). 'Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia.' Circulation 94(7): 1647-1654. Wang, G. L. and G. L. Semenza (1995). 'Purification and characterization of hypoxia-inducible factor 1.' J Biol Chem 270(3): 1230-1237. Wang, L., D. Wei, et al. (2003). 'Transcription factor Sp1 expression is a significant predictor of survival in human gastric cancer.' Clin Cancer Res 9(17): 6371-6380. Whisenant, J. and E. Bergsland (2005). 'Anti-angiogenic strategies in gastrointestinal malignancies.' Curr Treat Options Oncol 6(5): 411-421. Whiteway, M., R. Freedman, et al. (1987). 'The yeast ARD1 gene product is required for repression of cryptic mating-type information at the HML locus.' Mol Cell Biol 7(10): 3713-3722. Whiteway, M. and J. W. Szostak (1985). 'The ARD1 gene of yeast functions in the switch between the mitotic cell cycle and alternative developmental pathways.' Cell 43(2 Pt 1): 483-492. Wykoff, C. C., C. W. Pugh, et al. (2000). 'Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.' Oncogene 19(54): 6297-6305. Xiao, D. and S. V. Singh (2007). 'Phenethyl isothiocyanate inhibits angiogenesis in vitro and ex vivo.' Cancer Res 67(5): 2239-2246. Xie, K. and S. Huang (2003). 'Regulation of cancer metastasis by stress pathways.' Clin Exp Metastasis 20(1): 31-43. Yao, J. C., L. Wang, et al. (2004). 'Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer.' Clin Cancer Res 10(12 Pt 1): 4109-4117. Yi, C. H., D. K. Sogah, et al. (2007). 'A genome-wide RNAi screen reveals multiple regulators of caspase activation.' J Cell Biol 179(4): 619-626. Yokozaki, H., W. Yasui, et al. (2001). 'Genetic and epigenetic changes in stomach cancer.' Int Rev Cytol 204: 49-95. Zetter, B. R. (1998). 'Angiogenesis and tumor metastasis.' Annu Rev Med 49: 407-424. Zheng, L., L. Wang, et al. (2004). 'Molecular basis of gastric cancer development and progression.' Gastric Cancer 7(2): 61-77. | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/44771 | - |
| dc.description.abstract | 胃癌高居世界十大癌症死因第二位，導致胃癌死亡率居高、治癒率低的原因，主要為癌細胞之轉移而造成治療失敗。因此研究抑制癌細胞轉移之機轉，在癌症治療領域佔有重要的角色。在像胃癌這樣的實體腫瘤中，腫瘤的增大進而轉移的過程亟需新生血管與週邊組織連結，以運輸腫瘤所需之養分。若能找出具抑制腫瘤血管新生作用之蛋白，並釐清其機制，可做為作為病理診斷上的新方法，及未來治療癌症的方向。
ARD1 在1985年即被發現在酵母菌中扮演著轉換細胞有絲分裂及發育機轉之角色，ARD1和其共同作用者NATH可形成一個穩定的結構，此結構具有N基乙醯轉移酵素之活性，並參與許多生物性功能如細胞分化，熱敏感性，細胞凋亡等。本篇研究結果顯示，臨床上分析ARD1蛋白表現量較低的病人，與較早癌病復發率、較短存活時間，以及癌病惡性度較高有正相關。在體外細胞株實驗當中，收集不同胃癌細胞株的細胞培養液處理內皮細胞，發現ARD1的mRNA及蛋白表現量和其影響內皮細胞之移動與新生血管能力有負相關性。在ARD1過度表現之轉殖細胞株中發現顯著降低內皮細胞的移動與新生血管能力；相反的，在ARD1表現降低的轉殖株中則促進內皮細胞的移動與新生血管能力。此外，雞胚胎卵黃囊試驗法(CAM)與小黑鼠體內血管新生(Matrigel Plug assay)中，同樣觀察到ARD1顯著降低血管生成與發育。最後藉由動物實驗，再次印證ARD1在活體實驗當中也有效抑制腫瘤血管新生。 進一步探討ARD1所調控之轉移能力之機轉則發現，ARD1可減少ARNT (HIF-1β)的RNA與蛋白表現，進而抑制其所調控之基因啟動子上的缺氧反應元(HRE)活性，使下游基因(如血管內皮生成因子基因)表現減少。我們也證明了ARD1本身之N基乙醯轉移酵素活性並不影響其調控血管新生之能力。因此，ARD1為一個新發現之抑癌基因並可作為將來治療腫瘤血管新生的標的因子。 | zh_TW |
| dc.description.abstract | Gastric cancer is one of the leading causes of cancer-related death worldwide, and metastasis is the major cause of treatment failure and mortality in cancer patients. Angiogenesis, the formation of new blood vessels from the existing vessels, depends on the homeostasis of a variety of pro- and anti-angiogenic factors. Tumor angiogenesis is induced by the secretion of angiogenic factors from cancer cells, and is essential for the growth and progression of solid tumors, including gastric cancer. Identification of novel tumor angiogenesis-associated genes and elucidation of their mechanism of action may provide new insights into the pathogenesis and management of cancer metastasis.
Arrest defective protein 1 (ARD1) is characterized as an N-acetyltransferase. It forms heterodimer with human N-acetyltransferase (NATH) and exerts N-acetyltransferase activity in many biological processes such as cell cycle regulation and cell proliferation. The purpose of this study is to investigate the regulatory role of ARD1 in tumor angiogenesis. In the present study, we found that ARD1 expression was inversely correlated with patients’ survival, stage and tumor status, as well as angiogenesis abilities in gastric cancer cell lines. By using cell wounding and capillary tube formation on a matrigel matrix, we found that ARD1 decreased gastric cancer cell-induced angiogenesis, migration and tube formation in endothelial cells. In addition, ARD1 also suppressed gastric cancer cell-induced angiogenesis in chick chorioallantoic membrane (CAM) assay and matrigel plug assay. Furthermore, in vivo xenograft mouse model showed that ARD1 inhibited tumor growth, tumor microvessel density, and distal organ metastasis. We further demonstrated that ARD1 suppressed cancer cell-induced angiogenesis through down regulating the expression of ARNT (HIF-1β) and decreasing the transcriptional activity of HIF-1α/HIF-1β, which may result in reduction of downstream genes. In conclusion, we considered ARD1 as an anti-angiogenesis gene and it inhibited cancer cell-induced angiogenesis through reducing ARNT expression. Therefore, ARD1 may be a potential target for cancer treatment. | en |
| dc.description.provenance | Made available in DSpace on 2021-06-15T03:54:34Z (GMT). No. of bitstreams: 1 ntu-99-R96447007-1.pdf: 2087020 bytes, checksum: 85f4cf7d3b3d7ef116dadba2684236d9 (MD5) Previous issue date: 2010 | en |
| dc.description.tableofcontents | 中文摘要…………………………………………………………4
Abstract…………………………………………………………5 Introduction……………………………………………………7 Materials and Methods………………………………………11 Results…………………………………………………………18 Discussion ……………………………………………………26 Reference………………………………………………………31 Figures and Figure Legends ………………………………37 Table……………………………………………………………54 | |
| dc.language.iso | en | |
| dc.subject | 血管新生 | zh_TW |
| dc.subject | 胃癌 | zh_TW |
| dc.subject | Gastric cancer | en |
| dc.subject | Angiogenesis | en |
| dc.title | ARD1在人類胃癌腫瘤血管新生之角色探討 | zh_TW |
| dc.title | The role of Arrest defective-1 protein (ARD1) in gastric cancer angiogenesis | en |
| dc.type | Thesis | |
| dc.date.schoolyear | 98-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 莊雙恩,夏興國,張金堅,林明燦 | |
| dc.subject.keyword | 胃癌,血管新生, | zh_TW |
| dc.subject.keyword | Gastric cancer,Angiogenesis, | en |
| dc.relation.page | 54 | |
| dc.rights.note | 有償授權 | |
| dc.date.accepted | 2010-06-29 | |
| dc.contributor.author-college | 醫學院 | zh_TW |
| dc.contributor.author-dept | 毒理學研究所 | zh_TW |
| 顯示於系所單位： | 毒理學研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| ntu-99-1.pdf 未授權公開取用 | 2.04 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。